pI: 6.4178 |
Length (AA): 526 |
MW (Da): 58742 |
Paralog Number:
8169
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
39 | 334 | 2ozo (A) | 167 | 533 | 25.00 | 0.00003 | 0.86 | 0.59631 | 1 |
124 | 478 | 5awm (A) | 7 | 362 | 75.00 | 0 | 1 | 1.60569 | -1.43 |
139 | 521 | 4ysj (A) | 26 | 380 | 24.00 | 0 | 1 | 0.787224 | 0.54 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 40.4% | 349 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 45.0% | 358 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 33.9% | 304 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 41.4% | 152 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 26.8% | 306 aa | Compounds | References |
Rattus norvegicus | c-Jun N-terminal kinase 3 | 464 aa | 69.5% | 393 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 34.0% | 306 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 34.9% | 307 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-B | 368 aa | 24.4% | 299 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-A | 361 aa | 24.7% | 299 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 33.7% | 306 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 8 | 411 aa | 72.4% | 366 aa | Compounds | References |